MTIP
NVAX icon

Magee Thomson Investment Partners’s Novavax NVAX Stock Holding History

Magee Thomson Investment Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,016
Closed -$239K – 119
2014
Q4 		$239K Buy
2,016
+494
+32% +$51.6K 0.06% 48
2014
Q3 		$128K Hold
1,522
– – 0.03% 83
2014
Q2 		$142K Hold
1,522
– – 0.03% 84
2014
Q1 		$139K Hold
1,522
– – 0.03% 85
2013
Q4 		$157K Buy
+1,522
New +$108K 0.03% 82

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Magee Thomson Investment Partners's NVAX Position: Q1 2015 in Review

Magee Thomson Investment Partners sold out of Novavax (NVAX) in Q1 2015, closing a stake of 2,016 shares — an estimated $239K sold.

Magee Thomson Investment Partners first reported a position in NVAX in Q4 2013 and held it in 5 quarters. The position peaked at $239K in Q4 2014. 167 funds tracked by Wall St. Rank hold NVAX as of Q1 2015.

  • Magee Thomson Investment Partners reported no remaining Novavax position as of Q1 2015 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 2,016 Novavax shares in Q1 2015, an estimated $239K.
  • Magee Thomson Investment Partners first reported a position in Novavax in Q4 2013 and held it in 5 quarters.
  • Magee Thomson Investment Partners's Novavax position peaked at $239K in Q4 2014.
  • 167 funds tracked by Wall St. Rank held Novavax as of Q1 2015.

Based on Magee Thomson Investment Partners's 13F filing for Q1 2015, filed 4 May 2015.